A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,706,663 shares of OCUL stock, worth $29.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,706,663
Previous 2,706,663 -0.0%
Holding current value
$29.2 Million
Previous $18.5 Million -0.0%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $11.4 Million - $23.5 Million
2,706,663 New
2,706,663 $18.5 Million
Q3 2022

Nov 14, 2022

SELL
$4.09 - $6.5 $200,410 - $318,500
-49,000 Reduced 98.0%
1,000 $4,000
Q2 2022

Aug 15, 2022

BUY
$3.01 - $5.22 $150,500 - $261,000
50,000 New
50,000 $201,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $830M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.